Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Chlorophyllin e4 is a novel photosensitizer against human bladder cancer cells.
Li B, Wu Z, Li W, Jia G, Lu J, Fang J, Chen G.
Oncol Rep. 2012 May;27(5):1455-60. doi: 10.3892/or.2012.1656. Epub 2012 Jan 26.
Related citations
p53 codon 72 polymorphism as a progression index for bladder cancer.
Lin HY, Huang CH, Yu TJ, Wu WJ, Yang MC, Lung FW.
Oncol Rep. 2012 Apr;27(4):1193-9. doi: 10.3892/or.2011.1610. Epub 2011 Dec 22.
HDAC6 and SIRT2 promote bladder cancer cell migration and invasion by targeting cortactin.
Zuo Q, Wu W, Li X, Zhao L, Chen W.
Oncol Rep. 2012 Mar;27(3):819-24. doi: 10.3892/or.2011.1553. Epub 2011 Nov 15.
Partial sensitization of human bladder cancer cells to a gene-therapeutic adenovirus carrying REIC/Dkk-3 by downregulation of BRPK/PINK1.
Jin Y, Murata H, Sakaguchi M, Kataoka K, Watanabe M, Nasu Y, Kumon H, Huh NH.
Oncol Rep. 2012 Mar;27(3):695-9. doi: 10.3892/or.2011.1543. Epub 2011 Nov 10.
Chondroitin sulphate enhances the antitumor activity of gemcitabine and mitomycin-C in bladder cancer cells with different mechanisms.
Ferro M, Giuberti G, Zappavigna S, Perdonà S, Facchini G, Sperlongano P, Porto S, Di Lorenzo G, Buonerba C, Abbruzzese A, Altieri V, Caraglia M.
Oncol Rep. 2012 Feb;27(2):409-15. doi: 10.3892/or.2011.1526. Epub 2011 Oct 31.
Proteomic approaches to study epigallocatechin gallate-provoked apoptosis of TSGH-8301 human urinary bladder carcinoma cells: roles of AKT and heat shock protein 27-modulated intrinsic apoptotic pathways.
Chen NG, Lu CC, Lin YH, Shen WC, Lai CH, Ho YJ, Chung JG, Lin TH, Lin YC, Yang JS.
Oncol Rep. 2011 Oct;26(4):939-47. doi: 10.3892/or.2011.1377. Epub 2011 Jul 4.
Bufalin induces apoptosis through activation of both the intrinsic and extrinsic pathways in human bladder cancer cells.
Hong SH, Choi YH.
Oncol Rep. 2012 Jan;27(1):114-20. doi: 10.3892/or.2011.1451. Epub 2011 Sep 7.
Suppression of bladder cancer cell tumorigenicity in an athymic mouse model by adenoviral vector-mediated transfer of LRIG1.
Li F, Ye ZQ, Guo DS, Yang WM.
Oncol Rep. 2011 Aug;26(2):439-46. doi: 10.3892/or.2011.1304. Epub 2011 May 10.
Restoration of miR-517a expression induces cell apoptosis in bladder cancer cell lines.
Yoshitomi T, Kawakami K, Enokida H, Chiyomaru T, Kagara I, Tatarano S, Yoshino H, Arimura H, Nishiyama K, Seki N, Nakagawa M.
Oncol Rep. 2011 Jun;25(6):1661-8. doi: 10.3892/or.2011.1253. Epub 2011 Apr 8.
microRNA-21 modulates cell proliferation and sensitivity to doxorubicin in bladder cancer cells.
Tao J, Lu Q, Wu D, Li P, Xu B, Qing W, Wang M, Zhang Z, Zhang W.
Oncol Rep. 2011 Jun;25(6):1721-9. doi: 10.3892/or.2011.1245. Epub 2011 Apr 4.
Claudin-11 decreases the invasiveness of bladder cancer cells.
Awsare NS, Martin TA, Haynes MD, Matthews PN, Jiang WG.
Oncol Rep. 2011 Jun;25(6):1503-9. doi: 10.3892/or.2011.1244. Epub 2011 Apr 4.
LRIG1 combined with cisplatin enhances bladder cancer lesions via a novel pathway.
Li F, Yang W, Guo D, Hu Z, Xu H, Ye Z.
Oncol Rep. 2011 Jun;25(6):1629-37. doi: 10.3892/or.2011.1227. Epub 2011 Mar 22.
Efficacy of the EGFr inhibitor Iressa on development of chemically-induced urinary bladder cancers: dose dependency and modulation of biomarkers.
Lubet RA, Lu Y, Bode AM, You M, Verney ZM, Steele VE, Townsend R, Juliana MM, Grubbs CJ.
Oncol Rep. 2011 May;25(5):1389-97. doi: 10.3892/or.2011.1200. Epub 2011 Mar 1.
Heme oxygenase-1 promotes angiogenesis in urothelial carcinoma of the urinary bladder.
Miyake M, Fujimoto K, Anai S, Ohnishi S, Kuwada M, Nakai Y, Inoue T, Matsumura Y, Tomioka A, Ikeda T, Tanaka N, Hirao Y.
Oncol Rep. 2011 Mar;25(3):653-60. doi: 10.3892/or.2010.1125. Epub 2010 Dec 27.
mTOR inhibitors show promising in vitro activity in bladder cancer and head and neck squamous cell carcinoma.
Schedel F, Pries R, Thode B, Wollmann B, Wulff S, Jocham D, Wollenberg B, Kausch I.
Oncol Rep. 2011 Mar;25(3):763-8. doi: 10.3892/or.2011.1146. Epub 2011 Jan 14.
Human papillomavirus and non-muscle invasive urothelial bladder cancer: potential relationship from a pilot study.
Cai T, Mazzoli S, Meacci F, Nesi G, Geppetti P, Malossini G, Bartoletti R.
Oncol Rep. 2011 Feb;25(2):485-9. doi: 10.3892/or.2010.1083. Epub 2010 Dec 8.
Telomerase suppression initiates PML-dependent p53 activation to inhibit bladder cancer cell growth.
Xue Y, Li L, Zhang D, Wu K, Guo P, Zeng J, Wang X, He D.
Oncol Rep. 2010 Dec;24(6):1551-9.
Overexpression of BDNF and TrkB in human bladder cancer specimens.
Lai PC, Chiu TH, Huang YT.
Oncol Rep. 2010 Nov;24(5):1265-70.
VEGFR and EGFR inhibition increases epithelial cellular characteristics and chemotherapy sensitivity in mesenchymal bladder cancer cells.
Li Y, Yang X, Su LJ, Flaig TW.
Oncol Rep. 2010 Oct;24(4):1019-28.
Genetic polymorphisms in the DNA repair genes XPD and XRCC1, p53 gene mutations and bladder cancer risk.
Gao W, Romkes M, Zhong S, Nukui T, Persad RA, Smith PJ, Branch R, Keohavong P.
Oncol Rep. 2010 Jul;24(1):257-62.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on